Tyra Biosciences, Inc. (TYRA)
20.09
-0.30
(-1.47%)
USD |
NASDAQ |
Oct 08, 13:32
Tyra Biosciences Market Cap : 1.199B for Oct. 8, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 07, 2026 | 1.217B |
| October 06, 2026 | 1.208B |
| October 05, 2026 | 1.249B |
| October 02, 2026 | 1.219B |
| October 01, 2026 | 1.254B |
| September 30, 2026 | 1.305B |
| September 29, 2026 | 1.311B |
| September 28, 2026 | 1.280B |
| September 25, 2026 | 1.298B |
| September 24, 2026 | 1.337B |
| September 23, 2026 | 1.386B |
| September 22, 2026 | 1.526B |
| September 21, 2026 | 1.530B |
| September 18, 2026 | 1.535B |
| September 17, 2026 | 1.458B |
| September 16, 2026 | 1.453B |
| September 15, 2026 | 1.517B |
| September 14, 2026 | 1.496B |
| September 11, 2026 | 1.314B |
| September 10, 2026 | 1.404B |
| September 09, 2026 | 1.313B |
| September 08, 2026 | 1.595B |
| September 04, 2026 | 1.709B |
| September 03, 2026 | 1.483B |
| September 02, 2026 | 1.499B |
| Date | Value |
|---|---|
| September 01, 2026 | 1.509B |
| August 31, 2026 | 1.493B |
| August 28, 2026 | 1.488B |
| August 27, 2026 | 1.559B |
| August 26, 2026 | 1.564B |
| August 25, 2026 | 1.592B |
| August 24, 2026 | 1.557B |
| August 21, 2026 | 1.554B |
| August 20, 2026 | 1.533B |
| August 19, 2026 | 1.600B |
| August 18, 2026 | 1.554B |
| August 17, 2026 | 1.564B |
| August 14, 2026 | 1.509B |
| August 13, 2026 | 1.493B |
| August 12, 2026 | 1.509B |
| August 11, 2026 | 1.502B |
| August 10, 2026 | 1.566B |
| August 07, 2026 | 1.582B |
| August 06, 2026 | 1.609B |
| August 05, 2026 | 1.534B |
| August 04, 2026 | 1.941B |
| August 03, 2026 | 1.912B |
| July 31, 2026 | 1.896B |
| July 30, 2026 | 1.966B |
| July 29, 2026 | 1.850B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.498B |
| Oncolytics Biotech, Inc. | 68.55M |
| Sangamo Therapeutics, Inc. | 58.00M |
| Sarepta Therapeutics, Inc. | 1.888B |
| Anixa Biosciences, Inc. | 100.99M |
Market Cap Related Metrics
| PEG Ratio | -0.2476 |
| Price to Book Value | 3.389 |
| Price | 20.09 |
| Earnings Yield | -11.91% |
| PEGY Ratio | -0.2476 |